A New Orleans woman filed a legal dispute against the makers of Zantac (ranitidine) on June 11, 2020, stating that her leukemia diagnosis was caused by the use of the drug. Her lawsuit explains that she started taking Zantac in 2016 and continued use through August 2019, when she learned of the link between the medication and cancer. The woman is seeking compensation for her leukemia diagnosed in 2018, the case citing negligence, design defect, breach of warranties, and failure to warn.
How is Leukemia Linked to Zantac?
This lawsuit is one of a large number of cases stating that the manufacturers of Zantac were aware of or at least had the responsibility to know of the risk of cancer linked to the drug, and purposefully did not report the cancerous hazard to the medical community or the public. This situation was brought to light in 2019 when the drug testing company Valisure petitioned for a recall of Zantac after their routine testing of the drug showed excessive amounts of a carcinogen known as N-nitrosodimethylamine (NDMA). Continuing research has shown that these unacceptable levels of NDMA can further increase with a rise in temperature, including both in transportation and storage of the product, and after the drug is taken in the body.
Carcinogens such as NDMA can increase the risk of leukemia and other cancers by damaging and therefore altering the DNA in cells. While scientists don’t know the exact mechanism that causes leukemia, it seems to be a combination of environmental and genetic factors and is generally thought to develop when blood cells have mutations in DNA. These cells, most often white blood cells from the bone marrow, can sometimes grow exponentially due to certain mutations, leading to fewer healthy blood cells and possible tumor growth.
How can we help you?
Ranitidine has been nationally consumed and advertised as safe since introduced in the early 1980s. A large number of those taking Zantac have been doing so for years, possibly even decades, to treat their acid reflux and heartburn. Individuals diagnosed with leukemia after taking Zantac regularly deserve to be compensated for their suffering and our fierce legal team at Kwartler Manus, LLC. is ready to fight for the justice they deserve. In addition to leukemia, other cancers that may qualify for compensation include:
Small intestine cancer
If you or a loved one have been diagnosed with leukemia after consistent use of ranitidine, contact our experienced attorneys online or by phone at (267) 214-8608 today. We can guide you through this process and help you get compensated for your losses.